<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04902898</url>
  </required_header>
  <id_info>
    <org_study_id>49616/11.05.2021</org_study_id>
    <nct_id>NCT04902898</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of the Sterile Single-use Circular Stapling Device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China)</brief_title>
  <acronym>CiCi-2021</acronym>
  <official_title>Evaluation of the Safety and Efficacy of the Sterile Single-use Circular Stapling Device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China) in Adult Patients Suffering From Pathologic Foreskin (Phimosis, Stenosis, Redundant Prepuce): A Prospective Randomised Comparative Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Thessaly</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Thessaly</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the safety and efficacy of the sterile single-use circular stapling device&#xD;
      CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China) in comparison&#xD;
      with circumcision in adults patients with pathological foreskin (phimosis, stenosis,&#xD;
      redundant prepuce)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Number of gauzes used intraoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative hematoma</measure>
    <time_frame>First postoperative day</time_frame>
    <description>Measurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative hematoma</measure>
    <time_frame>Seventh postoperative day</time_frame>
    <description>Measurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative oedema</measure>
    <time_frame>Twenty first postoperative day</time_frame>
    <description>Measurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of procedure</measure>
    <time_frame>Intraoperative (Measurement begins at the time of the beginning of the sterilisation of the surgical field and ends at the time of the completion of the bandeage of the wound)</time_frame>
    <description>Minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative oedema</measure>
    <time_frame>First postoperative day</time_frame>
    <description>Measurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative oedema</measure>
    <time_frame>Seventh postoperative day</time_frame>
    <description>Measurement defined as follows: mild=1, moderate=2 and large=3, according to the surgeon's estimation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aesthetic result</measure>
    <time_frame>Nineteenth postoperative day</time_frame>
    <description>Visual analogue scale from 0 to 10, as follows: 0 - 5 = unsatisfactory, 6 - 7 = moderately satisfactory, 8 - 9 = very satisfactory, 10 = excellent, according to the patient's estimation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain feeling</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Visual analogue scale from 0 to 10, as follows: 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-9 = very severe pain and 10 = worst possible pain, according to the patient's estimation</description>
  </other_outcome>
  <other_outcome>
    <measure>Anaesthesia</measure>
    <time_frame>Immediately preoperatively</time_frame>
    <description>Quantity of applied lidocaine hydrochloride 2% w/v in milliliters</description>
  </other_outcome>
  <other_outcome>
    <measure>Used sutures</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Absolute number of used sutures</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Phimosis</condition>
  <condition>Foreskin; Tightness</condition>
  <condition>Redundant Prepuce</condition>
  <arm_group>
    <arm_group_label>Circumcision</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adult patients treated with circumcision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Circumcision with device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Adult patients treated with sterile single-use circular stapling device CIRCCURERII (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Circumcision in adults using sterile single-use circular stapling device</intervention_name>
    <description>Circumcision in adults using sterile single-use circular stapling device CIRCCURER II (Jiangxi Langhe Medical Instrument Co., Ltd., Guangzhou, China)</description>
    <arm_group_label>Circumcision with device</arm_group_label>
    <other_name>Sterile single-use circular stapling device</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Circumcision in adults</intervention_name>
    <description>Circumcision in adults</description>
    <arm_group_label>Circumcision</arm_group_label>
    <other_name>Circumcision</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :phimosis, stenosis of foreskin, redundant prepuce&#xD;
&#xD;
        Exclusion criteria : active inflammation of foreskin&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only males suffer from foreskin pathologic conditions</gender_description>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vasileios Tzortzis, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology Department, University of Thessaly, University Hospital of Larissa, Greece</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vasileios Tzortzis, Professor</last_name>
    <phone>00302413502811</phone>
    <email>urologydpt.uth@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lampros Mitrakas, Consultant</last_name>
    <phone>00302413501325</phone>
    <email>lamprosmit@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Urology Department, University of Thessaly, University Hospital of Larissa</name>
      <address>
        <city>Larissa</city>
        <state>Larissa/Thessaly</state>
        <zip>41110</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasileios Tzortzis, Professor</last_name>
      <phone>00302413502811</phone>
      <email>urologydpt.uth@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Lampros Mitrakas, Consultant</last_name>
      <phone>00302413501325</phone>
      <email>lamprosmit@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Vasileios Tzortzis, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lampros Mitrakas, Consultant</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 13, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2021</study_first_posted>
  <last_update_submitted>June 17, 2021</last_update_submitted>
  <last_update_submitted_qc>June 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Thessaly</investigator_affiliation>
    <investigator_full_name>Vasileios Tzortzis</investigator_full_name>
    <investigator_title>Professor of Urology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phimosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>After a publication and for a period of 2 years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

